Bio-rad Laboratories, Inc. Earnings

Bio-rad Laboratories, Inc.’s revenue jumped 0.5% since last year same period to $653Mn in the Q3 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 0.21% jump in its revenue since last 3-months.

Bio-rad Laboratories, Inc.’s net profit fell -152.34% since last year same period to $-341.9Mn in the Q3 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated -207.58% fall in its net profits since last 3-months.

Bio-rad Laboratories, Inc.’s net profit margin fell -152.08% since last year same period to -52.36% in the Q3 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated -207.35% fall in its net profit margins since last 3-months.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.55 - a -5.9% fall from last quarter’s estimates.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.55.

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Bio-rad Laboratories, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.